Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery.
Authors: Authors: Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH.
Am J Obstet Gynecol
View full abstract on Pubmed
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
Authors: Authors: Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC.
Pediatr Infect Dis J
View full abstract on Pubmed
Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum.
Authors: Authors: Andrews WW, Shah SR, Goldenberg RL, Cliver SP, Hauth JC, Cassell GH.
Obstet Gynecol
View full abstract on Pubmed
Isolation of Ureaplasma urealyticum from low birth weight infants.
Authors: Authors: Waites KB, Cassell GH, Duffy LB, Searcey KB.
J Pediatr
View full abstract on Pubmed
Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation.
Authors: Authors: Zheng X, Teng LJ, Watson HL, Glass JI, Blanchard A, Cassell GH.
Infect Immun
View full abstract on Pubmed
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough.
Authors: Authors: Davis SF, Sutter RW, Strebel PM, Orton C, Alexander V, Sanden GN, Cassell GH, Thacker WL, Cochi SL.
Clin Infect Dis
View full abstract on Pubmed
Severe Mycoplasma disease--rare or underdiagnosed?
Authors: Authors: Cassell GH.
West J Med
View full abstract on Pubmed
Size variation of a major serotype-specific antigen of Ureaplasma urealyticum.
Authors: Authors: Zheng X, Teng LJ, Glass JI, Blanchard A, Cao Z, Kempf MC, Watson HL, Cassell GH.
Ann N Y Acad Sci
View full abstract on Pubmed
Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene.
Authors: Authors: Teng LJ, Zheng X, Glass JI, Watson HL, Tsai J, Cassell GH.
J Clin Microbiol
View full abstract on Pubmed
Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection.
Authors: Authors: Waites KB, Sims PJ, Crouse DT, Geerts MH, Shoup RE, Hamrick WB, Duffy LB, Cassell GH.
Pediatr Infect Dis J
View full abstract on Pubmed